You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KROS Award Disclosure
Seth Alpna · SEC Form 4 · Filed Jun 5, 2026
Award
Calculated transaction value
$0
Seth Alpna Director
KROS
Keros Therapeutics
KROS
Transaction date
Jun 3, 2026
Public filing date
Jun 5, 2026
Filing lag
Filed 2 days later
KROS daily price context
Close on/before transaction
$10.5
Jun 3, 2026
First close after public filing
$10
Jun 8, 2026
30-day return after filing
+10.3%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,142 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001721020-26-000004
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Keros Therapeutics, Inc. KROS Current | Award | Jun 3, 2026 | $0 |
| Keros Therapeutics, Inc. KROS | Award | Jun 3, 2026 | $0 |